Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tvardi Therapeutics, Inc. | 53,365 | reported | 05 Apr 2024 | tx 42+607,507−79,142 |
| Oruka Therapeutics, Inc. | 40,377 | reported | 15 May 2026 | tx 38+360,000−70,641 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 6.84 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 7.80 USD | 10b5-1 |
| 15 May 2026 | SALE | Oruka Therapeutics, Inc. | 4,800 | 61.56 USD | 10b5-1 |
| 15 May 2026 | SALE | Oruka Therapeutics, Inc. | 2,100 | 62.42 USD | 10b5-1 |
| 15 May 2026 | SALE | Oruka Therapeutics, Inc. | 100 | 63.52 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 0.00 USD | 10b5-1deriv |
| 15 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 0.00 USD | 10b5-1deriv |
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 1,177 | 41.94 USD | |
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 2,902 | 41.20 USD | |
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 2,921 | 40.11 USD | |
| 16 Mar 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 7.80 USD | |
| 16 Mar 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 6.84 USD | |
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 641 | 41.30 USD | |
| 16 Mar 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 17 Feb 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 6.84 USD | |
| 17 Feb 2026 | SALE | Oruka Therapeutics, Inc. | 936 | 32.78 USD | |
| 17 Feb 2026 | SALE | Oruka Therapeutics, Inc. | 6,064 | 32.30 USD | |
| 17 Feb 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 7.80 USD | |
| 17 Feb 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 17 Feb 2026 | EXERCISE | Oruka Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 32,500 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 15 Jan 2026 | SALE | Oruka Therapeutics, Inc. | 2,619 | 32.24 USD | |
| 15 Jan 2026 | SALE | Oruka Therapeutics, Inc. | 4,381 | 31.56 USD |